Breaking News Instant updates and real-time market news.

SASR

Sandy Spring Bancorp

$39.49

0.48 (1.23%)

, FULT

Fulton Financial

$17.95

0.25 (1.41%)

04:55
08/15/18
08/15
04:55
08/15/18
04:55

Stephens to hold a bank trip

Mid-Atlantic Bank Trip travels throughout Washington, D.C., Pennsylvania, West Virginia and Maryland to visit with various banking companies on August 14-15.

SASR

Sandy Spring Bancorp

$39.49

0.48 (1.23%)

FULT

Fulton Financial

$17.95

0.25 (1.41%)

WSBC

WesBanco

$49.72

0.62 (1.26%)

UBSI

United Bankshares

$39.10

0.75 (1.96%)

EGBN

Eagle Bancorp

$54.30

0.6 (1.12%)

ANCX

Access National

$27.68

0.035 (0.13%)

OLBK

Old Line Bancshares

$34.42

-0.1 (-0.29%)

HBMD

Howard Bancorp

$16.55

-0.15 (-0.90%)

  • 15

    Aug

  • 12

    Sep

  • 24

    Sep

SASR Sandy Spring Bancorp
$39.49

0.48 (1.23%)

02/22/18
SPHN
02/22/18
UPGRADE
Target $45
SPHN
Overweight
Sandy Spring Bancorp upgraded to Overweight with $45 target at Stephens
As previously reported, Stephens analyst Austin Nicholas upgraded Sandy Spring Bancorp to Overweight from Equal Weight as he forecasts above peer profitability in 2019 and a sub 50% efficiency run-rate even before accounting for any benefit from rising interest rates. The analyst, who notes that Sandy Spring shares underperformed over the last, believes integration risk from the bank's recently closed WashingtonFirst transaction has been priced in, he tells investors. Nicholas set a $45 price target on Sandy Spring shares.
06/26/18
06/26/18
UPGRADE
Target $48

Buy
Sandy Spring Bancorp upgraded to Buy ahead of Q2 report at Sandler ONeill
As previously reported, Sandler ONeill analyst Casey Whitman upgraded Sandy Spring Bancorp to Buy from Hold after raising his 2018 and 2019 EPS estimates following the company's Q1 report and ahead of its upcoming Q2 report. The first quarter included a full quarter with WashingtonFirst results and he "liked what we saw," Whitman tells investors. He has a $48 price target on Sandy Spring shares.
06/26/18
SDLR
06/26/18
UPGRADE
SDLR
Buy
Sandy Spring Bancorp upgraded to Buy from Hold at Sandler O'Neill
04/24/18
KBWI
04/24/18
UPGRADE
Target $47
KBWI
Outperform
Sandy Spring upgraded to Outperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Catherine Mealor upgraded Sandy Spring Bancorp to Outperform and raised her price target for the shares to $47 from $44. The upward trend in consensus estimates is not reflected in the current valuation, Mealor tells investors in a research note. She believes the stock is undervalued following last week's "strong" Q1 results.
FULT Fulton Financial
$17.95

0.25 (1.41%)

07/19/18
PIPR
07/19/18
UPGRADE
Target $19
PIPR
Overweight
Fulton Financial upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Matthew Breese upgraded Fulton Financial to Overweight and raised his price target for the shares to $19 from $18.50. The stock "looks attractive" following the company's "strong" Q2 results, which included better than anticipated net interest margin expansion and credit results, Breese tells investors in a research note. The analyst believes Fulton's balance sheet is "well-suited for the current environment."
03/26/18
DADA
03/26/18
INITIATION
DADA
Neutral
Fulton Financial initiated with a Neutral at DA Davidson
DA Davidson analyst Russell Gunther initiated Fulton Financial with a Neutral rating and $18 price target, seeing little upside to current levels.
WSBC WesBanco
$49.72

0.62 (1.26%)

10/20/17
DADA
10/20/17
NO CHANGE
Target $47
DADA
Buy
WesBanco price target raised to $47 from $44 at DA Davidson
DA Davidson analyst Russell Gunther raised his price target on WesBanco to $47 and maintained a Buy rating despite the Q3 EPS miss. Gunther says the bank's $10B asset threshold will produce a loan portfolio quality remix given increased selectivity and heightened focus on risk-adjusted returns, adding that the stock offers discounted valuation of about 10% relative to regional peers.
10/20/17
SDLR
10/20/17
DOWNGRADE
Target $44
SDLR
Hold
WesBanco downgraded to Hold from Buy at Sandler O'Neill
Sandler O'Neill analyst Casey Whitman downgraded WesBanco to Hold citing valuation with the shares approaching his price target of $44.
12/21/17
DADA
12/21/17
NO CHANGE
Target $48
DADA
Buy
WesBanco shares attractive at current levels, says DA Davidson
DA Davidson analyst Russell Gunther views current levels as an attractive entry point for shares of WesBanco. The analyst raised his price target for the stock to $48 from $47 and reiterates a Buy rating on the name. He believes the WesBanco's "accretive crossing" of $10B in assets is underappreciated.
UBSI United Bankshares
$39.10

0.75 (1.96%)

EGBN Eagle Bancorp
$54.30

0.6 (1.12%)

07/20/18
KBWI
07/20/18
NO CHANGE
Target $65
KBWI
Outperform
Eagle Bancorp selloff post earnings overdone, says Keefe Bruyette
Keefe Bruyette analyst Catherine Mealor views yesterday's post-earnings pullback in shares of Eagle Bancorp as overdone. The analyst lowered her price target for the stock to $65 from $70 and keeps an Outperform rating on the name. While the quarter was in-line, the 168% deposit beta is what drove the stock, Mealor tells investors in a research note. The analyst points out that even with the beta, net interest margin "held the line" at 4.15%, only down two basis points.
12/04/17
SDLR
12/04/17
NO CHANGE
Target $65
SDLR
Buy
Eagle shares pricing in 'enough of the bad news,' says Sandler O'Neill
Sandler O'Neill analyst Casey Whitman believes "enough of the bad news has been baked in" with Eagle Bancorp shares down 25%. Following a short report, the fundamental question is the legality of the actions the bank and the CEO have taken, and the company's press releases seem to address those concerns, Whitman tells investors in a research note. He sees the worst case scenario as the regulators do find a problem and/or the CEO must step down. Whitman has a buy rating on Eagle with a $65 price target.
12/04/17
BOSC
12/04/17
NO CHANGE
BOSC
Outperform
Eagle Bancorp coverage suspended at Boenning & Scattergood
After a short seller report that claimed or insinuated that Eagle Bancorp was guilty of material violations of Regulation O, Boenning & Scattergood analyst Matthew Schultheis suspended coverage of the stock, stating the firm is "reallocating resources...until there is further clearness surrounding these issues." Prior to the suspension, Schultheis had an Outperform rating and $75 price target on Eagle Bancorp, but the firm said its previous rating and estimates "should not be relied on from this point."
01/19/18
SPHN
01/19/18
UPGRADE
Target $69
SPHN
Overweight
Eagle Bancorp upgraded to Overweight from Equal Weight at Stephens
Stephens analyst Austin Nicholas upgraded Eagle Bancorp to Overweight from Equal Weight, as he sees the bank's Q4 beat as evidence that its high-growth, efficient business model is intact. He thinks the stock should trade at a modest premium to Eagle's regional peers and in-line with its high profitability peers. Nicholas set a $69 price target on Eagle Bancorp shares.
ANCX Access National
$27.68

0.035 (0.13%)

11/16/17
SPHN
11/16/17
INITIATION
Target $31
SPHN
Overweight
Access National initiated with an Overweight at Stephens
Stephens analyst Austin Nicholas started Access National with an Overweight rating and $31 price target, citing its above peer ROTCE in 2018, more stable earnings and position in DC Metro, which he views as one of the best banking markets.
07/10/18
RAJA
07/10/18
DOWNGRADE
RAJA
Market Perform
Access National downgraded to Market Perform from Outperform at Raymond James
11/16/17
11/16/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Vantiv (VNTV) initiated with a Buy at Berenberg. 2. Sea Limited (SE) initiated with a Buy at Citi. 3. Nomad Foods (NOMD) initiated with a Buy at Berenberg. 4. Access National (ANCX) initiated with an Overweight at Stephens. 5. TPI Composites (TPIC) initiated with an Outperform at JMP Securities. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/26/17
10/26/17
UPGRADE
Target $31

Outperform
Access National upgraded to Outperform following Q3 beat at Raymond James
As previously reported, Raymond James upgraded Access National to Outperform from Market Perform and established a $31 price target. Analyst William Wallace said Q3 results beat expectations on strong operating results as loan growth was higher than expected. Wallace expects the company to deliver positive operating leverage in the coming quarters and is incrementally more positive given an increased earnings outlook and above peer profitability.
OLBK Old Line Bancshares
$34.42

-0.1 (-0.29%)

05/03/18
HOVD
05/03/18
INITIATION
HOVD
Outperform
Old Line Bancshares initiated with an Outperform at Hovde Group
07/26/18
SDLR
07/26/18
DOWNGRADE
SDLR
Hold
Old Line Bancshares downgraded to Hold from Buy at Sandler O'Neill
Sandler O'Neill analyst Casey Whitman downgraded Old Line Bancshares citing valuation and maintained a $38 price target.
HBMD Howard Bancorp
$16.55

-0.15 (-0.90%)

08/21/17
RAJA
08/21/17
UPGRADE
RAJA
Strong Buy
Howard Bancorp upgraded to Strong Buy from Outperform at Raymond James
07/10/18
RAJA
07/10/18
DOWNGRADE
RAJA
Market Perform
Howard Bancorp downgraded to Market Perform from Outperform at Raymond James
10/20/17
RAJA
10/20/17
DOWNGRADE
Target $23
RAJA
Outperform
Howard Bancorp downgraded to Outperform from Strong Buy at Raymond James
Raymond James analyst William Wallace downgraded Howard Bancorp to Outperform from Strong Buy but increased its price target to $23 from $22. The analyst said shares are nearly trading at his price target following Q3 results that missed across the board driven by lower fee income and higher operating expenses. Wallace is disappointed but believes the longer-term thesis remains intact and is confident in management's ability to execute on its growth strategy.
06/14/18
KBWI
06/14/18
INITIATION
Target $19
KBWI
Market Perform
Howard Bancorp initiated with a Market Perform at Keefe Bruyette
Keefe Bruyette analyst Catherine Mealor started Howard Bancorp with a Market Perform rating and $19 price target. The analyst sees downside to consensus estimates, which she believes will likely weigh on shares in the near-term.

TODAY'S FREE FLY STORIES

ALGT

Allegiant Travel

$124.89

-1.45 (-1.15%)

18:37
12/10/18
12/10
18:37
12/10/18
18:37
Hot Stocks
Allegiant reports November total systems traffic up 10.1% »

Reports total systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPLK

Splunk

$108.55

2.85 (2.70%)

18:27
12/10/18
12/10
18:27
12/10/18
18:27
Periodicals
Splunk CEO says customers can now talk via voice-enabled assistants, CNBC says »

Splunk president and CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 19

    Dec

  • 20

    Dec

  • 09

    Jan

EFC

Ellington Financial

$15.57

0.01 (0.06%)

18:22
12/10/18
12/10
18:22
12/10/18
18:22
Hot Stocks
Ellington Financial reports book value per share of $19.37 as of Nov. 30th »

Ellington Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTDOY

Nintendo

$0.00

(0.00%)

18:22
12/10/18
12/10
18:22
12/10/18
18:22
Periodicals
New 'Smash Bros.' fastest selling Switch game so far, Gamesindustry.biz says »

Nintendo's latest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,040.02

3.5 (0.34%)

, GOOGL

Alphabet Class A

$1,052.80

5.81 (0.55%)

18:15
12/10/18
12/10
18:15
12/10/18
18:15
Periodicals
Google CEO supports privacy law, denies political bias, Bloomberg says »

Google CEO Sundar Pichai…

GOOG

Alphabet

$1,040.02

3.5 (0.34%)

GOOGL

Alphabet Class A

$1,052.80

5.81 (0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 03

    Mar

APTI

Apptio

$37.86

-0.17 (-0.45%)

18:13
12/10/18
12/10
18:13
12/10/18
18:13
Downgrade
Apptio rating change  »

Apptio downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NMRK

Newmark

$8.56

0.21 (2.52%)

18:00
12/10/18
12/10
18:00
12/10/18
18:00
Hot Stocks
Newmark CEO Barry Gosin buys over $2.6M in company shares »

Newmark CEO Barry Gosin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVTC

Evertec

$26.83

-0.365 (-1.34%)

17:52
12/10/18
12/10
17:52
12/10/18
17:52
Hot Stocks
Evertec EVP Ramirez sells 44,378 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

  • 18

    Dec

ALTM

Altus Midstream Company

$8.50

0.6 (7.59%)

, APA

Apache

$31.27

-1.74 (-5.27%)

17:46
12/10/18
12/10
17:46
12/10/18
17:46
Hot Stocks
Apache reports 13.4% stake in Altus Midstream Company »

This stake allows for…

ALTM

Altus Midstream Company

$8.50

0.6 (7.59%)

APA

Apache

$31.27

-1.74 (-5.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHT

Red Hat

$177.13

0.03 (0.02%)

, IBM

IBM

$121.13

1.77 (1.48%)

17:45
12/10/18
12/10
17:45
12/10/18
17:45
Hot Stocks
Red Hat sets January 16 special meeting for vote on IBM merger »

Red Hat, Inc. (RHT)…

RHT

Red Hat

$177.13

0.03 (0.02%)

IBM

IBM

$121.13

1.77 (1.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

YMAB

Y-mAbs Therapeutics

$22.17

-0.36 (-1.60%)

17:42
12/10/18
12/10
17:42
12/10/18
17:42
Hot Stocks
Y-mAbs Therapeutics humanized bispecific GD2 antibody IND receives FDA clearance »

Y-mAbs Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Shares

$117.68

-0.39 (-0.33%)

17:39
12/10/18
12/10
17:39
12/10/18
17:39
Hot Stocks
SPDR Gold Shares holdings rise to 760.32MT from 759.73MT »

This is the second…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAEX

SAExploration

$3.33

-0.11 (-3.20%)

17:35
12/10/18
12/10
17:35
12/10/18
17:35
Syndicate
SAExploration files to sell common stock for holders »

SAExploration filed to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHVN

Biohaven Pharmaceutical

$40.47

-0.25 (-0.61%)

17:27
12/10/18
12/10
17:27
12/10/18
17:27
Syndicate
Breaking Syndicate news story on Biohaven Pharmaceutical »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WCC

Wesco

$49.28

-0.675 (-1.35%)

17:26
12/10/18
12/10
17:26
12/10/18
17:26
Initiation
Wesco initiated  »

Wesco initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

MTEM

Molecular Templates

$4.30

-0.08 (-1.83%)

17:25
12/10/18
12/10
17:25
12/10/18
17:25
Initiation
Molecular Templates initiated  »

Molecular Templates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

COHR

Coherent

$119.34

-0.28 (-0.23%)

17:23
12/10/18
12/10
17:23
12/10/18
17:23
Initiation
Coherent initiated  »

Coherent initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAMP

CalAmp

$17.02

-0.23 (-1.33%)

17:22
12/10/18
12/10
17:22
12/10/18
17:22
Hot Stocks
CalAmp announces $20M stock repurchase program »

CalAmp announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CR

Crane

$78.23

-0.99 (-1.25%)

17:22
12/10/18
12/10
17:22
12/10/18
17:22
Initiation
Crane initiated  »

Crane initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BTX

BioTime

$1.31

-0.03 (-2.24%)

17:22
12/10/18
12/10
17:22
12/10/18
17:22
Initiation
BioTime initiated  »

BioTime initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVAX

Novavax

$2.14

0.09 (4.39%)

17:20
12/10/18
12/10
17:20
12/10/18
17:20
Initiation
Novavax initiated  »

Novavax initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$207.84

-3.275 (-1.55%)

17:19
12/10/18
12/10
17:19
12/10/18
17:19
Initiation
Lennox initiated  »

Lennox initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

FCAU

Fiat Chrysler

$15.33

(0.00%)

17:17
12/10/18
12/10
17:17
12/10/18
17:17
Hot Stocks
Breaking Hot Stocks news story on Fiat Chrysler »

Tiger Global reports 5.1%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$169.61

1.24 (0.74%)

17:15
12/10/18
12/10
17:15
12/10/18
17:15
Recommendations
Apple analyst commentary  »

Apple pullback is a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWK

Stanley Black & Decker

$121.93

-0.69 (-0.56%)

17:14
12/10/18
12/10
17:14
12/10/18
17:14
Initiation
Stanley Black & Decker initiated  »

Stanley Black &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.